“Pharmaceutical companies have never had it so good”, argues FT columnist Brooke Masters, pointing to the sector’s sudden PR rehabilitation, riding a wave of vaccine goodwill. But as the current debate over the Oxford/AstraZeneca vaccine’s safety neatly illustrates: public trust can be eroded far more quickly than it can be won.
For in-house comms teams at pharma and healthcare companies, the pandemic has undoubtedly created golden opportunities. But it has also generated bigger risks at a time when the usual comms channels have been turned on their heads, stakeholders are urgently seeking reassurance, and internal resources are stretched to their limits.
Does this description sound familiar? If so, we want to hear from you. We are surveying in-house healthcare comms professionals to learn more about their changing roles, pressures and priorities during the pandemic.
The short survey takes just five minutes to complete and responses are anonymous. The results will inform an upcoming report setting out the challenges and opportunities in a post-pandemic world.
Click here to take part in our survey, which generates a £5* donation to our nominated charity, The Trussell Trust, for every response we receive. We’re eager to hear your views, so please take part and share with your colleagues.
*Up to a maximum donation of £250.